Callan Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
27,337
+19,203
| +236% | +$889K | 0.04% | 354 |
|
|
2025
Q1 | $496K | Sell |
8,134
-3,505
| -30% | -$214K | 0.04% | 320 |
|
|
2024
Q4 | $658K | Buy |
11,639
+7,035
| +153% | +$398K | 0.04% | 319 |
|
|
2024
Q3 | $238K | Buy |
+4,604
| New | +$238K | 0.04% | 163 |
|
|
2023
Q2 | – | Sell |
-9,682
| Closed | -$671K | – | 115 |
|
|
2023
Q1 | $671K | Buy |
+9,682
| New | +$671K | 0.16% | 79 |
|